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Glioblastoma (GBM) is well known to have one of the poorest prognoses among all cancers. Patients with 
GBM in progression-free survival (PFS) may be relatively stable and can often maintain their quality of life. Thus, 
PFS is a desirable goal. In Japan, the median PFS is 11 months. It is difficult to grasp a patient's thoughts and hopes 
when, after PFS, they are readmitted due to recurrence or acute deterioration. Therefore, this study aimed to describe 
the lived experience of illness in patients with recurrent GBM, focusing on PFS. We enrolled five patients into the 
study; however, only four patients completed data collection. Data were collected using semi-structured interviews. 
We also conducted a thematic narrative analysis. As a result, we generated one overall theme: Even in vulnerable 
and constrained daily lives, the aim was gaining a sense of stability—and maintaining it steadily—as far as possible, 
on their own. That sense of stability is fragile so that maintaining equilibrium is a precarious enterprise. Moreover, 
in PFS, participants were trying to maintain equilibrium by reevaluating themselves and sometimes giving up some-
thing, although they received support from people around them. We infer that it is important for nurses to assess and 
understand the fluctuations in that sense of stability through continuous involvement with patients. An interdiscipli-
nary approach and lateral integration of care are important to meet the needs of GBM patients. This understanding 
will lead to nursing supports that help patients live with stability, pride, and dignity. 
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Gliomas account for 28.3% of primary brain 
tumors. In Japan, gliomas occur at a rate of 6.6 per 
100,000 persons (Committee of Brain Tumor Regis-
try of Japan, 2014). According to the World Health 
Organization, gliomas Grades III and IV are malig-
nant. Glioblastoma (GBM; Grade IV) is known to 
have one of the poorest prognoses among all cancers, 
and the median survival rate is 12-15 months (com-
pared with 2-5 years for anaplastic astrocytoma, 
Grade III; Pompili, Telera, Villani, & Pace, 2014). 
Reports show that of the 1,381 newly diagnosed 
GBM patients in Japan, 52.9% already have a severe 
neurological deficit (Narita & Shibui, 2015); the on-
set of disease may be acute or insidious (Cahill & 
Armstrong, 2011). Treatment extends the overall sur-
vival rate. However, worsening of existing neurologi-
cal deficits, the appearance of new symptoms and 
treatment-associated symptoms may compromise 
their quality of life (Cahill & Armstrong, 2011). 
Although tumor control or shrinkage by initial 
treatment may improve signs, symptoms, and 
activities of daily living (ADL; Cahill & Armstrong, 
2011; Higuchi, Tanaka, Noguchi, & Kusumi, 2006; 
Tsumura, Yamazaki, & Kamibeppu, 2010), tumor 
recurrence is frequently unavoidable and incurable 
(Tsumura et al., 2010). 
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Maintaining a relatively stable quality of life 
without progression, regardless of how long it may 
last, is important for the patients considering GBM’s 
prognosis including the likelihood of additional neu-
rological deficits once recurrence starts. The median 
progression-free survival (PFS) period is 11 months 
(Committee of Brain Tumor Registry of Japan, 2017). 
When these patients are readmitted due to tumor re-
currence or if the tumor deteriorates because of neu-
rological deficits, it is crucial to grasp the nature of 
their thoughts and hopes because these thoughts and 
hopes may guide nurses to provide better care in their 
remaining time.  
Kleinman (1988) stated that illness is a lived 
experience; it can be narrated, and when caregivers 
understand its narrative patterns, they can optimally 
engage with the patient’s experience. Furthermore, 
Kleinman (1988) adds, “Legitimating the patient’s 
illness experience—authorizing that experience, au-
diting it empathically—is a key task in the care of the 
chronically ill” (p. 17). That legitimizing of experi-
ence requires enlightened listening to the narratives 
of patients with GBM throughout the trajectory of 
their illness. Therefore, nurses can intervene so that 
patients have quality time in PFS. 
Patients with high-grade glioma (HGG) are 
reported to experience loss of self, a sense of waiting 
and uncertainty, and focus on immediate needs in 
their illness trajectory (Philip et al., 2014). Other re-
search has reported that HGG patients with neurolog-
ical dysfunction suffer from the threat of a malignant 
brain tumor, confrontation with death, loss of feelings 
of self, loss of dignity, and a decline in self-reliance 
(Kamma, Sato, & Kuwabara, 2008). Sterckx et al. 
(2013) conducted a systematic review, which ana-
lyzed 16 qualitative studies of the impact of HGG on 
patients and caregivers’ everyday lives. Results found 
that at diagnosis, HGG patients felt shocked and rec-
ognized death. During different phases of the disease, 
patients felt uncertain about the effect HGG would 
have on their quality of life and future, and they suf-
fered from the loss of autonomy. In such circum-
stances, they needed hope, support, and information. 
However, these studies included HGG patients in 
various phases of the disease trajectory. For example, 
Umeda and Iwata (2015) reported that middle-aged 
HGG patients in PFS—including three GBM pa-
tients—were seeking a way of life that would ac-
commodate this critical, life-threatening experience, 
and the crisis of identity it brought. Furthermore, 
Iwata (1998) reported on a neurosurgeon and associ-
ate professor at a university hospital who suffered 
from GBM in his 40s, who recorded what he learned 
and felt after he became a patient. He felt fear that he 
could expect in detail what would happen to him in 
his illness trajectory and realized that there was a gap 
between patient’s need and actual medical care. As 
Kleinman (1988) observed, “The trajectory of chron-
ic illness assimilates to a life course, contributing so 
intimately to the development of a particular life that 
illness becomes inseparable from life history” (p. 8). 
Thus, to understand the subjective experiences of 
patients with GBM, it is necessary to understand 
them in their life context. We found no studies that 
described the subjective experience of GBM patients 
in PFS and considered the individual voices of pa-
tients. Consequently, this study aimed to describe the 
lived experience of illness in patients with recurrent 
GBM, focusing on the PFS stage of their lives.  
Method 
In this study, we defined the lived experi-
ence of illness as “How patients perceive, live with, 
and respond to symptoms and disability” (Kleinman, 
1988, p.3). We obtained ethical approval from the 
Kyoto University Graduate School and Faculty of 
Medicine, Kyoto University Hospital, Ethics Com-
mittee (R04730-1). 
Design 
We used a qualitative narrative study design 
to conduct the interviews: “Narrative inquiry enables 
participants to tell the story of their experience and 
provides an approach to the way people create mean-
ing in their lives by the way they construct their nar-
rative” (Davies, Crowe, & Whitehead, 2016, p, 534). 
Narrative inquiry elucidates the participant’s subjec-
tive experience. 
Participants 
Participants who were diagnosed with GBM 
recurrence and notified of their disease and its prog-
nosis were recruited at a department of neurosurgery, 
in a university hospital in Kyoto, Japan. Their physi-
cian, who is a co-author, introduced them to the study. 
We included participants if they were aged 20 years 
and above, were lucid according to the Japan coma 
scale (The Joint Committee on Guidelines for the 
Management of Stroke, 2009), and were able to read 
and communicate in Japanese (we excluded those 
with symptoms of aphasia).  
Data Collection 
We collected data using semi-structured in-
terviews and through the review of electronic medical 
records; we conducted interviews from May to De-
cember 2016 to explore participants’ experiences of 
living with GBM, including their life stories. The 
interviews were focused mainly on perceptions of 
their symptoms, current disease status, and prognosis.  
158




Table 1. Participant Characteristics 
Characteristic Ms. A Ms. B Mr. C Ms. D 
Age In her early thirties In her late sixties In his early thirties In her early thirties 
Marital status Unmarried Unmarried Unmarried Engaged 
Living arrangement Living 
with parents 
Living alone Living  
with parents 
Living  
with parents & fiancé 
Work status Employed Retired Unemployed On sick leave 
Diagnosis recurrent GBM recurrent GBM recurrent GBM recurrent secondary 
GBM 
Tumor location left frontal lobe right angular gyrus right supplementary 
motor area 
right frontal lobe 
Time since diagnosis 
(months) 
20  15  112  9  
PFS* (months) 6  18  73  6 
Off treatment duration 
before recurrence 
(months) 




surgical resection and 
interstitial CT with 
carmustine wafers 
CRT with TMZ 
 
surgical resection and 
interstitial CT with 
carmustine wafers 
CRT with TMZ 
 
surgical resection 
CRT with TMZ 
 
biopsy prior to RT 
against diffuse astro-
cytoma‡ 




6  17  47 7  
Note. CT = chemotherapy; CRT = chemoradiotherapy; TMZ = temozolomide; RT = radiotherapy 
*PFS (Progression-free survival): The length of time during and after the treatment of a disease, such as cancer, that patient lives 
with the disease, but it does not worsen (National Cancer Institute, n.d.). 
†Treatment history: The standard treatment for newly diagnosed GBM is surgical resection to the extent feasible, followed by 
concurrent chemoradiotherapy with TMZ, followed by TMZ monotherapy (Stupp et al., 2005). Furthermore, some new ap-
proaches such as carmustine wafers and bevacizumab have been covered by insurance in Japan since 2013. TMZ monotherapy is 
required to be a maximum of six courses in Europe and the United States (Stupp et al., 2005), which probably reflects the medical 
situation; but in Japan, more than six courses may be covered by the health insurance system depending on adverse events 
(Hashimoto, 2016) and patients’ choice. 
‡biopsy before RT against diffuse astrocytoma: Ms. D was at the onset of secondary GBM after she received these treatments 
about seven years ago. 
All participants were interviewed individually after 
using the Distress and Impact Thermometer (Akizuki, 
Yamawaki, Akechi, Nakano, & Uchitomi, 2005) as a 
brief screening tool for adjustment disorders or major 
depression in cancer patients. We conducted inter-
views for about one hour at a time. Furthermore, the 
investigator interviewed participants several times 
(whenever possible, deferring to the participant’s 
condition) when, during data analysis, the need arose 
for additional questions or analysis suggested a result 
that might differ from what subjects had reported.  
Data Analysis 
A thematic narrative analysis (Riessman, 
2008) was performed to describe the individual expe-
riences of illness in detail. It was challenging to re-
cruit subjects because GBM is rare and symptoms 
vary widely depending on the location of the tumor. 
Thus, we anticipated that the experience of each pa-
tient would be unique. A thematic narrative analysis 
was focused on the content of speech exclusively and 
works from a case-centered model that enables to the 
researcher to “keep a story ‘intact’ by theorizing from 
the case rather than component themes (categories) 
across cases” (Riessman, 2008, p. 53). 
We used the thematic-narrative analysis pro-
cedure to analyze the data (Braun & Clarke, 2006; 
Riessman, 1993, 2008). The interviewer transcribed 
interviews verbatim. Three investigators read the 
transcripts. Next, we analyzed each case ordering 
episodes into a chronological, biographical account, 
coding and identifying sub-themes and themes. In 
this analysis, we specifically focused on the experi-
ence of the period of PFS, from the end of the initial 
treatment to the recurrence. We then linked the 
themes among the four participant transcripts for a 
global analysis. We checked all themes presented in 
the data and individual analysis against each other 
and checked against the original data. Finally, we 
identified common themes and an overall main theme.  
Reflexivity and Rigor 
To ensure objectivity, we analyzed the inter-
view data independently and then discussed the data 
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with three investigators: a principal investigator and 
two collaborative researchers, both of whom had ex-
perience in qualitative research including narrative 
studies. Finally, we carefully triangulated the ana-
lyzed data with an expert researcher in palliative care 
nursing and qualitative research methods. Further-
more, to ensure the internal validity of the data inter-
pretation, the participants confirmed the results as 
much as possible (Sakurai & Kobayashi, 2005). 
Results 
Patient Characteristics 
The participants were originally five adult 
patients with recurrent GBM, two males and three 
females, who had varying levels of physical function 
but were all-lucid. Five patients consented to partici-
pate; the authors due to clinical deterioration, leaving 
four subjects to complete the study, withdrew one 
subject. The average age of the four participants was 
41.5 years (SD ± 17.8); the mean PFS was 28.7 
months (SD ± 32.0). Table 1 shows the participant 
characteristics.  
Patient Experience 
We analyzed the four chronological biologi-
cal accounts and identified themes in the experience 
of PFS per participant. We found four sub-themes 
from Ms. A, three sub-themes from Ms. B, two sub-
themes from Mr. C, and seven sub-themes from Ms. 
D. These themes, including the raw data, were com-
pared and linked in a global analysis. As a result, 
three common themes emerged: 
• Living vulnerable daily lives with uncertain-
ty about the future and physical symptoms. 
• Gaining a sense of normality and attempting 
to maintain it.  
• Coping with bouts of pain while maintaining 
that sense of normality in daily life. 
From these three themes, we distilled an overall main 
theme of the lived experience of GBM patients who 
had experienced PFS: Even in vulnerable and con-
strained daily lives, the aim was gaining a sense of 
stability—and maintaining it steadily—as far as pos-
sible, on their own. In the following sections, the 
details of those three common themes are described 
by referring to the raw data—translations from the 
participants’ own words. 
Living vulnerable daily lives with uncertain-
ty about the future and physical symptoms 
Participants knew the characteristics of 
GBM, including the fact of inevitable recurrence and 
prognosis. Furthermore, that knowledge made them 
aware of their limited life expectancy and uncertain 
future: 
• “I heard from my sister about the life expec-
tancy being two or three years. If it recurs, I 
do not know whether or not adequate treat-
ment is available, but I did hear that it will 
be sure to relapse, so I will cross that bridge 
when I come to it” —Ms. B. 
Moreover, participants had uncertainty about 
physical symptoms. They were always aware of the 
risks of sudden physical deterioration, such as a sei-
zure caused by GBM, and they maintained epilepsy 
precautions. Furthermore, the uncertainty led to men-
tal pain:  
• “I am not sure what will happen, I’m scared 
a bit…”—Ms. A. 
• “I heard [that I will] never know when I col-
lapse”—Ms. B.   
• “[Regarding preventive behavior] I think I 
should do it because I cannot do many 
things if I collapse. It’s important after 
all”—Ms. D. 
Under such circumstances, when the participants 
thought about their uncertain future, recurrence, and 
prognosis, they tried to be positive and focused on 
the immediate situation: 
• “I try to live every day with a smile as much 
as possible because my friends advised me 
that depression can accelerate the disease 
progression” —Ms. B. 
• “I need positive thinking to get me through 
[this] illness. I try to think positively rather 
than negatively because I become more and 
more negative when I think negatively”—
Ms. D. 
Each participant spent a stable everyday life 
in PFS although they realized that their disease would 
persist. Ms. A’s daily life was almost the same as her 
premorbid life, without subjective symptoms. Ms. B 
was proud that she had overcome another life crisis, 
precipitated by acute hydrocephalus, before GBM. 
She reported a life wherein she perceived GBM as a 
serious disease but also valued her own current good 
physical condition. Mr. C spent a life without subjec-
tive symptoms after reoperation. Finally, Ms. D be-
lieved she was gradually getting better and had a plan 
to return to work. Overall, during the PFS stage, 
these participants hoped that their condition would 
stabilize, and they were able to think a little optimis-
tically: 
• “[I think,] just vaguely, well, I guess I might 
die, but... I was hospitalized because I was 
about to die. Hmm..., I overcame that, so I 
wonder if it will work out in the future” —
Ms. B. 
• “After the second surgery, actually, my 
symptoms were getting better. I was okay af-
ter that, at that time”—Mr. C. 
• “I thought it would last—a good condition 
like this” — Ms. D.  
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In this way, they mentally distanced themselves from 
the dire prognosis that they had heard during hospi-
talization. 
The participants experienced recurrence. All 
of them recognized that they would relapse someday, 
but Mr. C and Ms. D, who had exacerbated symp-
toms, felt the effect of relapse more acutely. Ms. A 
and Ms. B did not notice symptoms, as they stated 
the following in a bland tone: 
• "I do not know [my condition] because I had 
no symptoms, but I realized it when I was 
shown my MRI image”—Ms. A.  
• “Although I relapsed…” —Ms. B.  
Mr. C and Ms. D both expressed their sur-
prise at relapse. Although Mr. C (the longest survi-
vor) knew recurrence was frequently unavoidable, he 
was surprised by not only the recurrence but also 
motor dysfunction because he had spent about six 
years without any dysfunction or relapse. Meanwhile, 
Ms. D (shortest survivor) thought there was still a 
considerable amount of time before relapse: 
• “Finally! It actually happened; I felt the time 
has come, but I never thought I would need 
a stick when I walk”—Mr. C. 
• “I began to collapse, but I never expected 
the recurrence; I thought that relapse was 
still a little way off”—Ms. D.  
These participants believed that they were 
getting better and regained their positive attitudes 
toward PFS. However, no one knew when the brain 
tumor would recur; its stability was always at risk, so 
they felt vulnerable in their daily lives. Even if the 
patients’ condition is, good and regardless of whether 
the disease duration is long or short, their vulnerabil-
ity remains as long as they have GBM. However, 
despite the vulnerability, they focused on the stable 
factors in their immediate situation rather than focus-
ing on the thoughts of an uncertain future. 
Gaining a sense of normality and attempting 
to maintain it 
During PFS, participants did not have physi-
cal pain from symptoms, but they did experience side 
effects such as nausea, anorexia, and constipation 
within five days of chemotherapy (temozolomide 
monotherapy for five days every four weeks). Partic-
ipants took constant precautions against epileptic 
seizures: 
• “Actually, I had nausea during taking te-
mozolomide. Because I never knew when I 
vomited, I was always in the kitchen when-
ever I vomited” —Mr. C. 
In their PFS situation, they adapted their dai-
ly lives (e.g., meals, means of transportation) to ac-
commodate their post-diagnosis situation. As the par-
ticipants met the needs that changed from their 
premorbid life, they reported little trouble; partici-
pants complimented those around them for assisting. 
Thereby, the participants obtained the subjective feel-
ing that they were spending normal lives. 
Ms. A did not experience any physical dis-
tress after being discharged from surgery. She re-
turned to work on the fifth day after discharge. She 
has become able to work as well as she did before the 
occurrence of disease, receiving assistance from oth-
ers in her surroundings: 
• “I returned to work from the beginning of 
the week after discharge; I was fine. I cannot 
drive a car now, so my parents ride to work. 
I told my boss about my disease”—Ms. A. 
Although Ms. B experienced a life crisis at 
the onset of GBM, the symptoms disappeared when 
she was discharged. Therefore, she could resume 
retirement life as she had lived before the occurrence 
of disease by substituting other means such as using 
personal deliveries for daily shopping and a micro-
wave without gas:  
• “I got well very much by rehabilitation after 
surgery, so I became rather normal. As rehab 
allowed my legs to move relatively quickly, 
and I could stand on one foot, actually I had 
not been having so much in trouble with dai-
ly life”—Ms. B. 
Although Mr. C had intermittent numbness 
in left his leg, he could do carpentry as he did before 
diagnosis. That work convinced him he was no dif-
ferent from a healthy person: 
• “The lumber was big, but I was strong 
enough for it. I did not feel that my physical 
strength had declined.” —Mr. C. 
Thus, three of the participants were able to 
realize normal functioning relatively early in PFS by 
keeping the ADL almost the same as before diagnosis. 
Ms. D thought she was no longer normal because 
surgery had lessened the fine motor function in her 
left hand. However, she felt she should be normal, 
and she pursued that goal by setting normal standards 
on her own. Because she went through a smooth re-
covery process supported by her loved ones, she was 
able to feel that she was normal: 
• “Although I think perhaps healthy persons 
who are not sick also have a day like they 
feel down, feel a bit badly today, and feel 
like spoiling myself. I think the normal is 
maybe that I can manage those kinds of 
things well by a change of pace, increasing 
motivation. So, I was like I evaluated myself 
by just wondering how much the days like 
that would increase”—Ms. D. 
Coping with bouts of pain while maintaining 
that sense of normality in daily life 
All of the participants lived in PFS with in-
dependent ADL, without symptoms that reminded 
them of their GBM. Thus, during PFS, the partici-
pants felt themselves to be normal despite their GBM 
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diagnosis. Still, at times, the participants suffered 
intractable pain. In particular, by leading a daily life 
that felt normal, they could feel they met even higher 
needs such as a self-actualization. The participants 
were aware of social pain. Saunders (1989) described 
the concept of pain by using the term "total pain," the 
sum of the physical, psychological, social, spiritual, 
and emotional elements that construct the total pain 
experience. Social pain refers to suffering to function 
every day, such as balancing the stressful situations 
of living with cancer, economic problems, work and 
resocialization, relationships with family, and care 
burdens (Japan Nursing Association, 2014). Partici-
pants suffered from increased living expenses includ-
ing medical expenses, a sense of guilt for burdening 
their families, and limitations on their hobbies and 
entertainment. 
Ms. A had no choice but to rely on her par-
ents for driving a car; she was sorry for her parents. 
She felt disgusted about her narrow range of activi-
ties. Furthermore, she was also concerned about per-
sistent hair loss from radiotherapy, and her body im-
age was changing— a major problem especially for a 
woman in her 30s: 
• “I’d like to drive extremely, as I can’t … No, 
not pain; actually, hair the loss was terrible 
— the most terrible thing. Around here, if 
you look closely, there is still no hair” —Ms. 
A. 
Ms. B looked back at her life and mused 
about the reason for getting GBM:  
• “I sometimes wonder if getting GBM is the 
punishment for many years of having [an] 
affair” —Ms. B. 
At the same time, she said it brought up the most 
important memories of her life. Furthermore, when 
considering her death vaguely, she expressed spiritual 
pain. She had hoped to live longer, and she had a hard 
time motivating herself to sort through her belong-
ings for her sisters. 
• “I sometimes wonder if I deserved it. Well, 
actually, I just wonder if it cannot be helped, 
and I cannot be cured because I am old 
enough and living alone. But I just think that 
I have to settle for things until death”—Ms. 
B.    
Mr. C reported no change regarding how to 
live, including his way of working. However, he did 
report economic distress from continuing the expen-
sive chemotherapy. He was suffering from unstable 
symptoms that appeared when he got tired. Although 
sometimes he had regrettable experiences while 
working, economic pressure forced him to work. He 
was a young, independent ADL, and ostensibly able 
to work normally. He was suffering from social pain 
because it was difficult for him to find good employ-
ers and to access social welfare systems other than 
high-cost medical expense benefit. Mr. C reported 
why he had no choice but to quit chemotherapy in the 
fifth year: 
• “I was no longer able to keep taking the 
medicine due to economic difficulty…but, I 
guess I have not been able to continue medi-
cine [temozolomide] without receiving wel-
fare like now. I am thinking that it cannot be 
helped though. Well, actually, my economic 
situation was so bad” —Mr. C.  
Ms. D felt that she was recovering smoothly 
and was able to think positively. However, as for her 
dysfunctional left hand, she wanted to return to nor-
mal—her health status before her diagnosis. She had 
concerns:  
• “Even though I know in my head that it [a 
complete cure] is impossible, I have gotten 
better. So, I cannot stop thinking, I wish I 
could return to my old self as premorbid.” 
—Ms. D. 
Furthermore, she was sorry to put a burden on her 
parents, and she worried about the future with her 
fiancé: 
• “I live in my parents’ house. Well, I cannot 
afford an apartment fee; I feel like I cannot 
survive unless I live with my parents. I am 
sorry for my parents, though”—Ms. D. 
Discussion 
This study has cast a spotlight on how GBM 
patients perceive their life and how they cope with 
their illness. It was important for them to acquire and 
maintain a sense of normality on their own for adap-
tation in PFS. The results of this study present critical 
insights for nursing, as nurses seek to give patients 
quality time in PFS, by supporting their sense of 
normality with an interdisciplinary approach and lat-
eral integration of care. We identified patients’ narra-
tives that may assist nurses to support patients, fami-
lies, and clinicians for decision-making to prepare for 
the death to come.  
The Meaning of Their Uncertainty 
Patients perceived that the uncertainty due to 
an illness restricted their daily lives. Their uncertainty 
was caused by an unclear future, unpredictable medi-
cal condition and treatment effect, and unfamiliar 
illness, GBM itself. Our results support Mishel’s ex-
planation, “Uncertainty is generated by events char-
acterized as vague, ambiguous, unpredictable, unfa-
miliar, in-consistent, or lacking information” (Mishel, 
1984, p. 163). The prognosis of GBM forces patients 
to face the limitation of life left, which perpetuates 
uncertainty.  However, participants were looking 
back on their life, considering what was now im-
portant for them in the light of continual uncertainty. 
Thus, the participants were aware of thinking posi-
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tively, focusing on their immediate lives, and setting 
their goals. Our results support Mishel’s explanation 
that “the new view of uncertainty as a natural phe-
nomenon is a new view of the world in which insta-
bility and fluctuation are natural and increase the 
person’s range of possibilities” (Mishel, 1990, p. 261). 
Eventually, they may have approached adaptation to 
their changed lives, which are proposed as the end 
state achieved after coping with uncertainty (Mishel, 
1990). The present results suggest that uncertainty, 
though fluctuating, is becoming weaker compared 
with what the participants felt at diagnosis. Although 
they kept relapse and death “in the back of their 
head,” those images faded somewhat. 
The Meaning of the Sense of Normal: 
Equilibrium 
Participants in the present study had few or 
no physical symptoms except during chemotherapy. 
They experienced normalcy in their daily lives. The 
participants adjusted to their lives with GBM by del-
egating tasks to loved ones to make their everyday 
lives appear normal.  
Johnson (1961) explained, “Equilibrium de-
rives primarily from this stability-constancy concept. 
Equilibrium is viewed rather as a stabilized, but more 
or less transitory, resting state in which the individual 
is in harmony within himself and with his environ-
ment” (p. 65). Also, equilibrium takes place at points 
that the patient feels optimal gratification and mini-
mal deprivation of his need-dispositions. We suggest 
that these patients felt the subjective sense of normal-
cy, that is, a sense of stability on their own through 
the re-establishment or maintenance of their equilib-
rium. However, it’s likely that the equilibrium of 
GBM patients is fragile; their sense of stability in-
cluded vulnerability. 
The Meaning of the Social Pain 
The participants often suffered social pain, 
although they had been performing ADLs inde-
pendently, without GBM symptoms, while they 
gained a sense of stability during their PFS. Partici-
pants had social pain in common, such as the burden 
placed on families, the difficulty in returning to and 
continuing work, limitations on former hobbies and 
entertainment, concern about their future, and living 
expenses including medical expenses.  
Notably, the three participants in their 30s 
(Ms. A, Mr. C, and Ms. D), had stronger social pain. 
Based on Erikson’s (1980) psychosocial theory of 
development, they were at the stage between young 
and middle adult. During these stages, significant 
relationships with marital partners and friends and 
working are important. No matter how they had been 
obtaining and maintaining a sense of stability on their 
own, it was often hard for them to accomplish the 
developmental challenges of their stage due to GBM. 
Therefore, they were sometimes frustrated because 
they were strongly aware of the restrictions on their 
daily lives. 
In comparison to the younger participants, 
Ms. B (in her late 60’s) had more frequent remarks 
about spiritual pain, such as thinking about the mean-
ing of illness and reflecting on her life. According to 
Erikson’s (1980) theory, Ms. B was at the develop-
ment stage of late adulthood, which involves accept-
ing that one’s life is one’s responsibility through 
much reflection. Her spiritual pain was particularly 
related to the Erikson’s development challenge of this 
stage.  
Implication for Nursing 
Any sense of stability among patients is 
likely to collapse because of living with an unpre-
dictable disease like GBM. There is a delicate bal-
ance involved in maintaining a stable state of equilib-
rium, which can easily fluctuate and result in a feel-
ing of vulnerability. Moreover, in PFS, subjects were 
trying to maintain equilibrium by themselves, some-
times by giving up something, although they received 
support from their loved ones.  
As a premise, nurses are required to under-
stand that patients are not necessarily optimistic just 
because they feel a sense of stability; they may also 
feel vulnerable at the same time. Also, through con-
tinuous involvement with patients, skilled nurses will 
grasp how each sense of stability fluctuates, and the 
nurses will provide support-oriented solutions, such 
as concrete and adequate information, that supports 
hope as much as possible. If at some point the patient 
is unable to feel hope, it would be helpful if we could 
connect the patient with a non-profit volunteer organ-
ization. However, currently in Japan, although there 
are organizations for children with intractable diseas-
es such as Make a Wish® Japan 
(http://www.mawj.org/en/), for adults, there is only 
the cancer salon aimed at peer-support for survivors. 
Social welfare support has little available if patients 
have no or mild disability. Even if the condition is 
stable and the patient can perform ADL independent-
ly, hope may dwindle; thus, it is urgent that we de-
velop support systems in light of the disease’s severe 
prognosis. Otherwise, regardless of what the patient 
chooses, it is necessary to support their choice and 
encourage their confidence in it. These interventions 
will lead to developing a good relationship and symp-
tom management and help patients prepare for the 
day to come, maximize inner stability, and optimize 
the choices they still have. Therefore, it is important 
for nurses to communicate effectively and integrate 
care laterally, including the hospital, outpatient set-
tings, hospice, and rehabilitation settings. In fact, the 
Japanese government is promoting “community-
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based integrated care systems,” to facilitate collabo-
ration among various occupations and organizations. 
These systems are planned for completion by 2025 
when Japan’s aging population is estimated to reach 
about 30% (Naruki, 2016). The system is still devel-
oping, and for these GBM patients in PFS, it is criti-
cal to promote the lateral integration of care as soon 
as possible. 
Limitations 
In this study, we interviewed patients after 
the recurrence of GBM. Although there is a possibil-
ity that their memories of what they narrated are not 
accurate, narrative inquiry is focused on the life his-
tory of patients to understand their subjective experi-
ence. Therefore, personal narrative is interpreted by 
the narrator at that time, is characterized by values 
and motivation, and is a subjective reality. As long as 
the narrative inquiry aims to understand subjective 
reality, internal validity is required rather than explor-
ing the only true story (Sakurai & Kobayashi, 2005). 
As we received suggestions during the analysis, we 
conducted as many additional interviews as possible 
to confirm the internal validity, depending on the 
condition of the patients. It was difficult to conduct 
additional interviews because of the physical and 
mental deterioration of the patients in several cases. 
GBM is a progressive disease, and the speed of pro-
gression after recurrence is often much faster than 
before its recurrence. Therefore, it cannot be said that 
we were able to collect all narratives. Furthermore, 
there were varying locations and symptoms of the 
tumor, duration of disease, and other factors in our 
participants. The tumor size and tumor location are 
significant because these affect the prognosis and 
various clinical symptoms. Because the tumor loca-
tion in our participants allowed maximum safe surgi-
cal resection, it may have been less disabling. Mean-
while, there are many patients with some disability in 
PFS. Further analysis is needed to consider the dif-
ferences in tumor location and symptoms, disease 
duration, genotype, and other factors. 
Conclusions 
Overall, the theme of the lived experience of 
illness in GBM patients focused on PFS can be ex-
pressed, even in vulnerable and constrained daily 
lives, the aim was gaining a sense of stability—and 
maintaining it steadily—as far as possible, on their 
own. Patients with GBM perceived restriction and 
vulnerability in daily life owing to chronic uncertain-
ty. Because of responding to this uncertainty, partici-
pants were able to adapt to how their lives had 
changed from pre-illness and to attain a sense of sta-
bility on their own. They then attempted to maintain a 
certain, stable feeling of living in the present moment. 
Nurses are required to understand and re-
spect patients’ situations. We suggest that in PFS, it is 
important for nurses to continue to engage with out-
patients, develop a good relationship through conver-
sations and symptom management, and help patients 
to prepare themselves for the end-of-life phase so that 
they can live as they wish and maintain an inner 
sense of stability. Thus, it is important for nurses to 
use effective communication in an interdisciplinary 
approach and lateral integration of care to meet the 
needs of GBM patients in PFS. However, further re-
search is needed, which includes larger ongoing co-
horts, to explore specific nursing interventions. 
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